Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs

Go back to Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
(NASDAQ: JAGX) Delayed: 2.61 +0.36 (16.00%)
Previous Close $2.25    52 Week High $4.60 
Open $2.28    52 Week Low $0.81 
Day High $2.77    P/E N/A 
Day Low $2.26    EPS $0.00 
Volume 278,888